A Champion Highlight, our newest Board Member, how to start your 2023 off right, and more in this Update.
The efficacy and safety of Epidiolex, an oral cannabidiol, in children and adults with Dravet syndrome and Lennox-Gastaut syndrome (LGS) were supported in a real-world setting, with benefits similar to those seen in previous clinical trials and expanded access programs (EAPs), a Spanish EAP study reported.
At least one psychiatric diagnosis was present in 70.2% of patients, while 49.8% had two or more diagnoses.
Vitamins have antioxidant, anti-inflammatory, and immunomodulatory effects, which can be beneficial for the treatment of epilepsy.
It is possible that this retention of the exact combination of features is impaired in people with chronic epilepsy. At least the findings of the current study point in this direction.
Cognitive behavioral therapy interventions were effective in improving depression and quality of life in patients with epilepsy, but not effective in controlling seizures.
CBD
Add-on CBD was associated with sustained seizure reduction up to 192 weeks with an acceptable safety profile and can be used for long-term treatment of treatment-resistant epilepsies.
People with diabetes can wear a device that measures blood glucose and delivers just the amount of insulin needed to return the glucose level to within bounds. Currently, people with epilepsy do not have access to an equivalent wearable device that measures a systemic indicator of an impending seizure and delivers a rapidly acting medication or other intervention (e.g., an electrical stimulus) to terminate or prevent a seizure.
The aim of the study was to examine whether epilepsy is an obstacle to desired friendship.
